GDF15 and myeloid sarcoma: Among younger individuals, a case-control study of 40 participants with obesity (mean age: 34 years) reported higher GDF-15 levels in patients with MS than in the control group without MS; nevertheless, GDF-15 concentration was not associated with any component of MS (27).